Exhibitor Spotlight Theaters
Please Note: The Exhibitor Spotlight Theaters are promotional activities and are not approved for continuing education credit. The content of the Exhibitor Spotlight Theaters are the opinions of the presenters and do not represent the position or the opinion of the American Association for Cancer Research® (AACR) or its members.
All Spotlight Theaters are located in the Sails Pavilion.
Browse Schedules by Category:
Events
Advances in biomodal’s Duet Multiomics Portfolio for 5- and 6-base Sequencing: Enabling Wholistic Understanding of Genetics and Epigenetics
Theater A
Presented by biomodal.
From Circulating Signals to Spatial Context: Multiomic Insights for Next‑Generation Cancer Research
Theater B
Presented by Illumina.
Witness the Impossible with 10x Genomics
Theater C
Presented by 10x Genomics.
Leveraging AI and Research Platforms to Accelerate Next-generation Biological Modalities
Theater D
Presented by ACROBiosystems.
Cytokine Profiling in Cancer Research using Luminex xMAP® Technology
Theater E
Presented by Luminex Corporation.
Proteomics Advances Cancer Research
Theater A
Presented by Olink Proteomics.
Advances in ctDNA Testing towards Biopharma Development & Clinical Dx
Theater B
Presented by Myriad Genetics.
Whole Genome Sequencing (WGS) on AXELIOS 1: Detecting Low-Levels of ctDNA with High Accuracy
Theater C
Presented by Roche Diagnostics Corporation.
From Model to Mechanism: Customizing In Vivo Pharmacology in Humanized Immune System (HIS) Mice for Translational Success
Theater D
Presented by Taconic Biosciences.
Transforming Pathology to 3D – Latest Developments of Micro-CT Imaging by 3DHISTECH – The Digital Pathology Company
Theater E
Presented by 3DHISTECH.
The Cancerguard® Test: Broadening Cancer Detection for a New Era of Screening
Theater A
Presented by Exact Sciences.
Beyond the Pilot: Scaling Multimodal AI and Lab-in-the-Loop for Breakthrough R&D
Theater B
Presented by Tempus.
Resolving Cancer Across Its Biological Layers with Single-Cell and Spatial Biology
Theater C
Presented by Bruker Spatial Biology.
Direct Targeted Methylation Sequencing (dTMS) with SureSelect: Targeted Long-read Sequencing for Native Variant and Methylation Profiling in Oncology
Theater D
Presented by Agilent Technologies.
Discovering Blood‑Based Signatures of Therapeutic Response or Adverse Events with NULISA™ Precision Proteomics Technology
Theater E
Presented by Alamar Biosciences.
TCGA and Beyond: Whole-Genome Data Powering the Next Era of Cancer Intelligence
Theater A
Presented by Inocras.
Leveraging Droplet Digital PCR (ddPCR) for MRD Detection and Monitoring in Solid Tumors and Heme Malignancies
Theater B
Presented by Bio-Rad Laboratories.
Accelerating Precision Oncology: Real-time Genomic and Epigenomic Profiling with Oxford Nanopore Sequencing
Theater C
Presented by Oxford Nanopore Technologies.
ATCC’s Advanced Human-Relevant Cancer Models: Enabling the Next Era of Precision Medicine
Theater D
Presented by ATCC.
Next Generation HSC and PBMC-Engrafted Mouse Models with Comprehensive Immune Cell Profiles for Preclinical Immuno-Oncology Applications
Theater E
Presented by The Jackson Laboratory.
Bridging the Translational Gap: Assessing the Predictive Value of NAMs and Humanized Mouse Models, with Insights from Myeloid-directed Cancer Drug Development
Theater A
Presented by Charles River.
Powering Clinical Decisions with Tissue Intelligence
Theater B
Presented by PredxBio.
Clarity at Every Stage: Accelerating and De‑Risking Oncology Development Through Biomarker Strategy
Theater C
Presented by Labcorp.
From Sample to Insight: How Genomic Technologies and Data Science are Driving Cancer Research and Drug Development
Theater D
Presented by QIAGEN.
AI Agent for Pharma R&D: Powering Next-Gen Drug Discovery & Development
Theater E
Presented by Owkin.
Innovations in Advanced Human‑Relevant 3D and Organoid Cancer Models: From KRAS Inhibition to Drug Response Profiling
Theater A
Presented by Corning Life Sciences.
Optimized DNA Fragmentation for Simultaneous Genome and Methylome Sequencing with Illumina 5-base Genome Solution
Theater B
Presented by Covaris.
M-Optimus-1: A Multimodal Foundation Model Unifying H&E, Bulk RNA-seq, scRNA-seq, and Visium Spatial Transcriptomics for Cancer Research
Theater C
Presented by Bioptimus.
Enhancing the Translatability of Biologic’s Immune Related Effects and Efficacy Using One Humanized Mouse Model
Theater D
Presented by genoway.
Applications for TCR Repertoire Profiling: Bridging the Gap between Repertoire Frequency and Functional Specificity
Theater E
Presented by Cellecta.
Metastatic Uveal Melanoma: Changing the Historical Management and Redefining What Survival Looks Like
Theater A
Presented by Immunocore.
Leveraging Whole Genome Sequencing in Multi-Study Prospective Trials using the TrueMRD Platform to Redefine Cancer State and Improve Patient Outcomes
Theater B
Presented by Veracyte.
Clinical Impact and Practical Applications of Testing for the Emergence of ESR1 Mutations in Patients With Advanced and Metastatic Breast Cancer
Theater C
Presented by AstraZeneca.
Spatial Biology in a Preclinical Setting with the MACSima® Platform
Theater D
Presented by Miltenyi Biotec B.V. & Co. KG
Seeing Cancer More Completely: A HiFi Approach to Cancer Genomics
Theater E
Presented by PacBio.
Samsung Organoids: Enhancing Translational Relevance in Oncology Drug Development
Theater A
Presented by Samsung Biologics.
Introducing a Novel Integrated Platform to Accelerate the Path from Biomarker Discovery to Signature
Theater B
Presented by Meso Scale Discovery.
Expression-Based Liquid Biopsy – Informing R&D and Patient Selection for the Next Generation of Precision Medicines
Theater C
Presented by Precede Biosciences.
Fantastic Cells and Where to Find Them: Targeted Spatial Proteomics for Precision Oncology
Theater D
Presented by Cell Signaling Technology.
Recent Technological Advances in Reference Standards to Better Support the Development, Validation and Monitoring of Liquid Biopsy, Epigenetics and Long-Read Sequencing Based Assays
Theater E
Presented by LGC Clinical Diagnostics.
